Valentin S. Moiseev
Moscow, MOW, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Antiviral Activity, Safety, and Tolerability of Multiple Ascending Doses of Elbasvir or Grazoprevir in Participants Infected With Hepatitis C Virus Genotype-1 or -3.
Journal: Clinical therapeutics
Published: December 11, 2017
Infective endocarditis: Importance of molecular biological techniques in etiological diagnosis
Journal: Terapevticheskii arkhiv
Published: December 23, 2016
Cardiac damage in liver cirrhosis in alcohol abusers
Journal: Terapevticheskii arkhiv
Published: September 17, 2016
Pharmacokinetics and safety of the anti-human cytomegalovirus drug letermovir in subjects with hepatic impairment.
Journal: British journal of clinical pharmacology
Published: June 15, 2016
The concurrence of kidney and liver dysfunctions in decompensated heart failure
Journal: Terapevticheskii arkhiv
Published: June 15, 2016
Clinical pharmacology and pharmacotherapy: Problems and disputable issues
Journal: Terapevticheskii arkhiv
Published: January 30, 2016
Perspectives for the Blockade of the Renin-angiotensin-aldesteron System and Modulation of Natriuretic Peptides System in the Treatment of Arterial Hypertension and Heart Failure
Journal: Kardiologiia
Published: December 03, 2015
Blood Content of Markers of Inflammation and Cytokines in Patients With Alcoholic Cardiomyopathy and Ischemic Heart Disease at Various Stages of Heart Failure
Journal: Kardiologiia
Published: September 01, 2015
Pharmacokinetics of fingolimod and metabolites in subjects with severe renal impairment: An open-label, single-dose, parallel-group study.
Journal: International journal of clinical pharmacology and therapeutics
Published: August 27, 2015
Contrast-induced acute kidney injury after primary percutaneous coronary interventions: Prevalence, predictive factors, and outcomes
Journal: Terapevticheskii arkhiv
Published: August 19, 2015
First Experience of Clinical Application of LCZ696 an AT1-angiotensin Receptors and Neprilysin Inhibitor in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Journal: Kardiologiia
Published: July 01, 2015
Last Updated: 09/26/2026